Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ghiath M. Sukhtian currently holds 3,458,571 shares of Outlook Therapeutics, Inc. (OTLK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ghiath M. Sukhtian has been a net buyer of OTLK stock. They have purchased $20.0M and sold $0 worth of shares.
Ghiath M. Sukhtian's most recent insider trade was on Mar 18, 2024, when they sold 3,458,571 shares at $0.00 per share.
Ghiath M. Sukhtian serves as Executive at Outlook Therapeutics, Inc. (OTLK). They have executed 12 insider transactions totaling $20.0M over their tenure at the company.
Ghiath M. Sukhtian holds the position of Executive at Outlook Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Ghiath M. Sukhtian has shown a buying trading pattern, with $20.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Ghiath M. Sukhtian was on Nov 29, 2021, when they purchased $20.0M worth of OTLK shares. This transaction involved 16,000,000 shares at $1.25 per share.
Ghiath M. Sukhtian currently owns 3,458,571 shares of Outlook Therapeutics, Inc. (OTLK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ghiath M. Sukhtian's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ghiath M. Sukhtian has 12 Form 4 filings on record as an insider at Outlook Therapeutics, Inc..
Set alerts for Ghiath M. Sukhtian and 40,000+ other insiders.